Ally Bridge Group

Asia; Hong Kong Hong Kong; North America
Is it you?
Investor info
Type
PE/Buyout
Stage focus
  • Seed Round,
  • Early stage VC,
  • Later stage VC,
  • PE Growth/Expansion,
  • Buyout
Geography focus
China, Europe, United States
Current fund size
$ 2,000,000
Industry focus
Description
Ally Bridge Group is a cross-border healthcare investment group that invests in multi stage life science companies in China, United States and Europe. The firm primarily focuses on the biopharmaceuticals, medical devices and healthcare technology sectors. It is based in Hong Kong, Hong Kong.
Relevant investments
  • Company
    Amount
    Round
  • Example example company Inc
    $ 1,000,000
    Investor meetings
  • Company & Company
    € 11,000,000
    Series C funding
  • Example
    $ 524,000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Life Sciences
Made with in San Francisco, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.